Breathe Technologies has received approval from the US Food and Drug Administration (FDA) for the use of BT-V2S ventilator in the home setting.

BT-V2S ventilator, a one-pound portable device, provides ventilation assistance to help select adult patients who suffer from respiratory insufficiency.

Breathe Technologies president and CEO Larry Mastrovich said that patients with advanced COPD frequently suffer a loss of mobility, which may accelerate their respiratory disease progression and lead to decreased functional abilities.

"We are delighted to be able to offer this technology for patients to use in their homes because it has the potential to significantly improve their ability to perform activities of daily living," Mastrovich added.